Literature DB >> 19604131

Label-free optical biosensor for probing integrative role of adenylyl cyclase in G protein-coupled receptor signaling.

Elizabeth Tran1, Ye Fang.   

Abstract

Adenylyl cyclase is considered as an integrator for receptor signaling. However, its integrative role in receptor signaling is largely studied at the level of point of contacts in complex pathways. Here we used forskolin as a pharmacological probe and the resonant waveguide grating (RWG) biosensor to examine the signal integration of G protein-coupled receptors (GPCRs) at the cyclase-cyclic AMP-PKA module. The biosensor is a refractive index sensitive optical biosensor that is capable of detecting ligand-induced dynamic mass redistribution in cells without labels and cellular manipulations. Stimulation of seven cell lines with forskolin led to distinct optical responses, indicative of distinct expressions and/or organization of cyclase isoforms. The forskolin response in A431 was sensitive to the activities of protein kinase A, Rho kinase, and MAP kinases. Desensitization assays showed that the forskolin pretreatment heterologously desensitized G(s) signaling, partially attenuated G(q) signaling, but had complicate impacts on G(i) signaling. This study documents the integrative role of adenylyl cyclase in GPCR signaling and the power of forskolin as a pharmacological probe to differentiate receptor signaling using the label-free biosensor cellular assays.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604131     DOI: 10.1080/10799890903052544

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  6 in total

1.  Dynamic mass redistribution assays decode surface influence on signaling of endogenous purinergic P2Y receptors.

Authors:  Elizabeth Tran; Haiyan Sun; Ye Fang
Journal:  Assay Drug Dev Technol       Date:  2011-11-08       Impact factor: 1.738

2.  Label-Free Receptor Assays.

Authors:  Ye Fang
Journal:  Drug Discov Today Technol       Date:  2011

3.  PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS.

Authors:  Ye Fang
Journal:  Expert Opin Drug Discov       Date:  2010-12       Impact factor: 6.098

4.  Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution.

Authors:  Lisa Forster; Steffen Pockes
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

5.  Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target.

Authors:  Megan Morse; Elizabeth Tran; Haiyan Sun; Robert Levenson; Ye Fang
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

6.  Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family.

Authors:  Megan Morse; Haiyan Sun; Elizabeth Tran; Robert Levenson; Ye Fang
Journal:  BMC Pharmacol Toxicol       Date:  2013-03-12       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.